Guideline on the requirements of external quality assessment programs in molecular pathology-Reference-Cited by-同舟云学术

Guideline on the requirements of external quality assessment programs in molecular pathology

Published:2012-12-19 Issue:1 Volume:462 Page:27-37
ISSN:0945-6317
Container-title:Virchows Archiv
language:en
Short-container-title:Virchows Arch

Author:

van Krieken J. Han,Normanno Nicola,Blackhall Fiona,Boone Elke,Botti Gerardo,Carneiro Fatima,Celik Ilhan,Ciardiello Fortunato,Cree Ian A.,Deans Zandra C.,Edsjö Anders,Groenen Patricia J. T. A.,Kamarainen Outi,Kreipe Hans H.,Ligtenberg Marjolijn J. L.,Marchetti Antonio,Murray Samuel,Opdam Frank J. M.,Patterson Scott D.,Patton Simon,Pinto Carmine,Rouleau Etienne,Schuuring Ed,Sterck Silke,Taron Miquel,Tejpar Sabine,Timens Wim,Thunnissen Erik,van de Ven Peter M.,Siebers Albert G.,Dequeker Elisabeth

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology,General Medicine,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00428-012-1354-4.pdf

Reference14 articles.

1. Dancey JE, Bedard PL, Onetto N, Hudson TJ (2012) The genetic basis for cancer treatment decisions. Cell 148:409–420

2. Pao W, Chmielecki J (2010) Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer. Nat Rev Cancer 10:760–774

3. Penzel R et al (2011) EGFR mutation detection in NSCLC—assessment of diagnostic application and recommendations of the German Panel for Mutation Testing in NSCLC. Virchows Arch 458:95–98

4. Dequeker E, Ligtenberg MJL, Vander Borght S, Van Krieken JJM (2011) Mutation analysis of KRAS prior to targeted therapy in colorectal cancer: development and evaluation of quality by a European external quality assessment scheme. Virchows Arch 459:155–160

5. Bellon E et al (2011) External quality assessment for KRAS testing is needed: setup of a European program and report of the first joined regional quality assessment rounds. Oncologist 16:467–478

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peer‐to‐peer validation of Ki‐67 scoring in a pathology quality circle as a tool to assess interobserver variability: are we better than we thought?;APMIS;2024-07

2. Comment on Bisson et al. Novel Approach to Proficiency Testing Highlights Key Practice Variations in Cancer Biomarker Delivery. J. Mol. Pathol. 2024, 5, 1–10;Journal of Molecular Pathology;2024-06-27

3. A Highly Sensitive XNA-Based RT-qPCR Assay for the Identification of ALK, RET, and ROS1 Fusions in Lung Cancer;Diagnostics;2024-02-24

4. A highly sensitive XNA-based RT-qPCR assay for the identification of ALK, RET, and ROS1 fusions in lung cancer;2024-01-23

5. Access and quality of biomarker testing for precision oncology in Europe;European Journal of Cancer;2022-11